Biovision Investor Conference
PDC*line Pharma has been selected to present at Biovision Investor Conference on June 5, 2014.
EFS
(Etablissement Français du Sang – French Blood Bank) transferred the PDC*vac technology to PDC*line Pharma, and provides us with privileged access to its research and GMP-compliant manufacturing infrastructures.
